Protecting Brain Health in Vascular Cognitive Impairment
Protecting Brain Health in Vascular Cognitive Impairment
Vascular cognitive impairment and dementia (VCID) is the second most common cause of dementia affecting millions of patients.
But no with no approved therapies.
Vascular cognitive impairment and dementia (VCID) is the second most common cause of dementia affecting millions of patients.
But no with no approved therapies.
Vascular cognitive impairment and dementia (VCID) is the second most common cause of dementia affecting millions of patients.
But no with no approved therapies.
OUR MISSION
OUR MISSION
To develop first-in-class therapies that preserve cognitive function by targeting the neurovascular drivers of brain disease.
To develop first-in-class therapies that preserve cognitive function in vascular dementia by targeting the neurovascular drivers of brain disease.
To develop first-in-class therapies that preserve cognitive function in vascular dementia by targeting the neurovascular drivers of brain disease.
ProNeurogen is developing PNA5, a glycosylated Mas receptor agonist, to treat vascular dementia. PNA5 is designed to protect brain health by stabilizing the neurovascular unit in patients and reducing brain inflammation.
ProNeurogen is developing PNA5, a glycosylated Mas receptor agonist, to treat vascular dementia. PNA5 is designed to protect brain health by stabilizing the neurovascular unit in patients and reducing brain inflammation.
ProNeurogen is developing PNA5, a novel Mas receptor agonist designed to protect brain health by stabilizing the neurovascular unit in patients with vascular cognitive impairment and dementia.
OUR MISSION
*These statements have not been evaluated by the Food and Drug Administration. ProNeurogen products are in development and are not intended to diagnose, treat, cure, or prevent any disease.
*These statements have not been evaluated by the Food and Drug Administration. ProNeurogen products are in development and are not intended to diagnose, treat, cure, or prevent any disease.
PNA5 Indications
PNA5 Indications
Vascular and Mixed Dementia
Vascular and Mixed Dementia
Vascular and Mixed Dementia
Vascular dementia is caused by decreased brain blood flow and increased brain inflammation.
Vascular dementia is caused by decreased brain blood flow and increased brain inflammation.
Chronic Pain
Chronic Pain
Approximately 100 million American adults suffer from chronic pain with an estimated societal cost of $600 billion annually.
Approximately 100 million American adults suffer from chronic pain with an estimated societal cost of $600 billion annually.
Parkinson's Dementia
Parkinson's Dementia
Up to 80% of people with Parkinson’s may develop Parkinson’s disease dementia.
Up to 80% of people with Parkinson’s may develop Parkinson’s disease dementia.
